Fabrizia Favale
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.
Journal: Blood advances
Published: October 12, 2023
Author Correction: JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm.
Journal: Nature communications
Published: December 23, 2022
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study.
Journal: Leukemia & lymphoma
Published: April 23, 2022
Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia.
Journal: British journal of haematology
Published: March 07, 2022
JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm.
Journal: Nature communications
Published: January 28, 2022
Dominance of an UBA1 mutant clone over a CALR mutant clone: from essential thrombocytemia to VEXAS.
Journal: Haematologica
Published: June 11, 2021
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience.
Journal: Leukemia & lymphoma
Published: October 05, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms.
Journal: Oncogene
Published: December 11, 2019
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.
Journal: Haematologica
Published: November 09, 2016
Last Updated: 09/26/2026